Evaluating the Carcinogenic Potential and Molecular Mechanisms of 6PPDQ in the Human Stomach Using Organoids and Bulk Sequencing Data: A Multi-Machine Learning Approach Combined with Computational Simulation

Read the full article See related articles

Discuss this preprint

Start a discussion What are Sciety discussions?

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

Background: The environmental contaminant 6PPD-quinone (6PPDQ), a tire rubber antioxidant derivative, has emerged as a potential health hazard, yet its association with gastric cancer (GC) remains unexplored. This study investigates the molecular mechanisms underlying 6PPDQ-induced GC using network toxicology. Methods: 6PPDQ targets were retrieved from PharmMapper and SwissTargetPrediction databases. GC-related datasets (GSE33335, GSE19826, GSE63089) were obtained from GEO for differential expression analysis and model construction, with GSE112369 (organoid) for validation. Weighted Gene Co-expression Network Analysis (WGCNA) identified disease modules and hub genes, combined with GeneCards screening. Intersection of 6PPDQ and GC targets yielded 19 cross-targets undergoing GO/KEGG enrichment and Protein-Protein Interaction (PPI) analysis. Machine learning algorithms (LASSO, Random Forest, SVM-RFE) and topological methods (DMNC, MCC, Degree, EPC) identified core targets, validated by molecular docking. Results: The 19 cross-targets were enriched in cell cycle regulation (G2/M transition), chromosomal organization, and kinase activity. KEGG analysis highlighted p53, PI3K-Akt, Ras, MAPK signaling pathways, and cancer metabolism. Multi-dimensional screening identified PLAU, MET, and CDK2 as core targets. The three-gene risk model showed robust predictive performance. Molecular docking confirmed strong 6PPDQ binding affinities: -8.3 kcal/mol (MET), -8.1 kcal/mol (CDK2), and -6.7 kcal/mol (PLAU). Conclusion: PLAU, MET, and CDK2 represent core targets in 6PPDQ-induced GC. 6PPDQ promotes tumorigenesis through metabolic reprogramming, hormone metabolism disruption, tumor microenvironment modulation, and PI3K-AKT-CDK2 axis activation. These findings elucidate 6PPDQ's oncogenic mechanisms and provide therapeutic targets for GC prevention.

Article activity feed